Sub-microscopic materials are now in hundreds of consumer products, and the tiny particles can defy standard physics and may pose a risk. The FDA is passing the buck to the EPA to regulate them. Janet Babin reports.
Cancer-causing byproducts forced the drug maker to stop production, leaving many in the developing world without inexpensive options for treating HIV. Activists want Big Pharma to step in. Helen Palmer reports.
The genetically modified tuber tastes terrible, but a special starch inside could mean big bucks to BASF. Europeans, however, are notoriously wary of modified crops. Lisa Napoli talks with Stephen Beard.
The EPA's new list of Energy Star-compliant computers comes out today, and PC makers have even set their sights on far exceeding the federal standards. Good news for the environment, not to mention all the money we'll save, Helen Palmer reports.
Congress is taking a closer look at Google's plan to buy DoubleClick. The $3.1 billion deal announced in April is awaiting approval from the FTC, but first it'll have to endure an investigation and hearings on Capitol Hill. Jeremy Hobson reports.
Farmers in Cuzco are resisting a government drive to grow genetically modified potatoes, fearing they might contaminate indigenous varieties and kill efforts to market their organic produce. Janet Babin reports.
The recording industry has made some major concessions that will allow webcasters to stay in business while the two sides try to hammer out an agreement on royalty rates. Pandora's Tim Westergren says it's a win for musicians and listeners.
Website domain names start with price tags under $10, but some people are flipping them for big profits in a market that's starting to see 8-figure transactions. Jeremy Hobson looks at what's driving up the price of virtual real estate.
Google may rule the search universe, but MapQuest still has a corner on the Internet mapping and direction market — for now. Google this morning launched a new application that it hopes will catapult its ranking. Dan Grech reports.
Thousands of young people who took Paxil are entitled to a share of a $42 million class action settlement, so one consumer watchdog group posted a video on YouTube to spread the word: If they want the cash, they gotta make the claim. Helen Palmer has the story.
